BioPharma Resources

Drug Trial Radar · NCT06976203

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 586 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

586

Planned (sponsor's estimate)

Start

Jul 21, 2025

Primary completion

Sep 11, 2028

Study completion Feb 23, 2029

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
May 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

Conditions

  • Alzheimer's Disease

Interventions

  • KarXTDrug

    Specified dose on specified days

  • KarX-ECDrug

    Specified dose on specified days

  • PlaceboOther

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog11)Time frame: At week 24
  2. Clinician's Interview-Based Impression Plus Caregiver Input (CIBIC+)Time frame: At week 24

Locations

129 sites in 17 countries. Site status is shown where the registry gives one.

  • Fullerton Neurology and Headache Center

    Fullerton, California · Recruiting

  • Irvine Clinical Research

    Irvine, California · Recruiting

  • Inglewood Clinical

    Los Angeles, California · Recruiting

  • Stanford Neuroscience Health Center

    Palo Alto, California · Recruiting

  • Local Institution - 0069

    San Diego, California · Withdrawn

  • Research of the Rockies

    Colorado Springs, Colorado · Recruiting

  • Neuropsychiatric Research Center of Southwest Florida

    Fort Myers, Florida · Recruiting

  • Local Institution - 0086

    Hallandale, Florida · Completed

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida · Recruiting

  • K2 MEDICAL Research THE VILLAGES

    Lady Lake, Florida · Recruiting

  • Intercoastal Medical Group

    Sarasota, Florida · Recruiting

  • USF Health Byrd Alzheimer's Institute

    Tampa, Florida · Recruiting

  • Local Institution - 0129

    The Villages, Florida · Not yet recruiting

  • Alzheimer's Research and Treatment Center

    Wellington, Florida · Recruiting

  • Great Lakes Clinical Trials - Andersonville

    Chicago, Illinois · Recruiting

  • Southern Illinois University School of Medicine

    Springfield, Illinois · Recruiting

  • Josephson Wallack Munshower Neurology, PC

    Indianapolis, Indiana · Recruiting

  • Boston Center for Memory

    Newton, Massachusetts · Recruiting

  • Local Institution - 0080

    Watertown, Massachusetts · Not yet recruiting

  • QUEST Research Institute

    Farmington Hills, Michigan · Recruiting

  • Private Practice - Dr. Ronald Louis Schwartz

    Hattiesburg, Mississippi · Recruiting

  • Local Institution - 0119

    Ridgewood, New Jersey · Withdrawn

  • The Cognitive and Research Center of New Jersey

    Springfield, New Jersey · Recruiting

  • Advanced Clinical Institute

    West Long Branch, New Jersey · Recruiting

  • Neurological Associates Albany

    Albany, New York · Recruiting

  • Dent Neurosciences Research Center, Inc

    Amherst, New York · Recruiting

  • University at Buffalo - UBMD Neurology

    Buffalo, New York · Recruiting

  • Local Institution - 0078

    Lake Success, New York · Withdrawn

  • Keystone Clinical Studies

    Plymouth Meeting, Pennsylvania · Recruiting

  • Local Institution - 0081

    Dallas, Texas · Not yet recruiting

  • Central Texas Neurology Consultants, PA

    Round Rock, Texas · Recruiting

  • Local Institution - 0076

    Renton, Washington · Completed

  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI)

    Buenos Aires, Argentina · Recruiting

  • CEN Centro Especializado en Neurociencias

    Córdoba, Argentina · Recruiting

  • Instituto Médico DAMIC

    Córdoba, Argentina · Recruiting

  • Resolution Psychopharmacology Research Institute

    Mendoza, Argentina · Recruiting

  • Hospital Italiano de Buenos Aires

    ABB, Buenos Aires F.D., Argentina · Recruiting

  • Centro Médico Luquez

    Córdoba, Córdoba Province, Argentina · Recruiting

  • University of the Sunshine Coast Birtinya

    Birtinya, Queensland, Australia · Recruiting

  • Local Institution - 0055

    Herston (rbwh Grounds), Queensland, Australia · Not yet recruiting

Showing 40 of 129 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.